96184-81-5

Basic information

• Product Name: 4-OXO-CYCLOHEXANECARBOXALDEHYDE
• Synonyms: 4-OXO-CYCLOHEXANECARBOXALDEHYDE;4-OXO-CYCLOHEXANECARBOXYALDEHYDE;Cyclohexanecarboxaldehyde, 4-oxo- (9CI);Cyclohexanone-4-carboxaldehyde;4-Formylcyclohexanone;4-oxocyclohexanecarbaldehyde;4-oxocyclohexane-1-carbaldehyde
• CAS NO: 96184-81-5
• Molecular Formula: C₇H₁₀O₂
• Molecular Weight: 126.15
• EINECS: 200-589-5
• Product Categories: ALDEHYDE
• Mol File: 96184-81-5.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 223 ºC
• Flash Point: 81 ºC
• Appearance: /
• Density: 1.151
• Vapor Pressure: 0.0963mmHg at 25°C
• Refractive Index: 1.54
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 4-OXO-CYCLOHEXANECARBOXALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-OXO-CYCLOHEXANECARBOXALDEHYDE(96184-81-5)
• EPA Substance Registry System: 4-OXO-CYCLOHEXANECARBOXALDEHYDE(96184-81-5)

Safety Data

• Hazardous Substances Data: 96184-81-5(Hazardous Substances Data)

Usage

General Description

4-OXO-CYCLOHEXANECARBOXALDEHYDE is a chemical compound with the molecular formula C7H10O2. It is a cyclic aldehyde with a six-membered ring structure and a carbonyl group. 4-OXO-CYCLOHEXANECARBOXALDEHYDE is used in organic synthesis as a building block for the manufacture of various pharmaceuticals, dyes, and perfumes. It is also used as a precursor in the production of insecticides and herbicides. 4-OXO-CYCLOHEXANECARBOXALDEHYDE has potential applications in the field of medicine and agrochemicals due to its unique chemical properties and reactivity.

InChI:InChI=1/C7H10O2/c8-5-6-1-3-7(9)4-2-6/h5-6H,1-4H2

Upstream product

• 94458-92-1 1-<(trimethylsilyl)oxy>cyclohexene-4-carboxaldehyde 
• 96184-80-4 8-(methoxymethylene)-1,4-dioxaspiro<4.5>decane 
• 93245-98-8 1,4-dioxaspiro[4.5]decane-8-carbaldehyde 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 874-61-3 4-oxocyclohexanecarboxylic acid 
• 38580-68-6 4-hydroxymethyl-cyclohexanone 

Downstream Products

• 96184-82-6 4-[(E)-2-(4-Oxo-cyclohexyl)-vinyl]-benzonitrile 
• 64908-75-4 (+/-)-cyclohexanone-4-carboxaldehyde dimethyl acetal 
• 101160-77-4 4-{2-[4-(2-Oxo-ethyl)-cyclohexyl]-ethyl}-benzonitrile 
• 96184-78-0 4-[2-(p-cyanophenyl)ethyl]cyclohexanone 
• 101160-78-5 4-{2-[4-(3-Oxo-propyl)-cyclohexyl]-ethyl}-benzonitrile 
• 101160-79-6 4-{2-[4-(4-Oxo-butyl)-cyclohexyl]-ethyl}-benzonitrile 
• 96184-45-1 4-{2-[((E)-4-Propenyl)-cyclohexyl]-ethyl}-benzonitrile 
• 96184-46-2 p-[2-(trans-4-(trans-1-butenyl)cyclohexyl)ethyl]-benzonitrile 
• 95906-31-3 p-[2-(trans-4-(trans-1-pentenyl)cyclohexyl)ethyl]-benzonitrile 
• 96184-47-3 p-[2-(trans-4-(trans-1-hexenyl)cyclohexyl)ethyl]benzonitrile 
• 96184-79-1 trans-4-[2-(p-cyanophenyl)ethyl]cyclohexanecarboxaldehyde 

Relevant articles and documents

Stereoselective total synthesis of (±)-vindeburnol and (±)-16-epi-vindeburnol

A concise stereoselective total synthesis of (±)-vindeburnol and its epimer (±)-16-epi-vindeburnol is presented. This synthetic work features the utilization of Baeyer-Villiger oxidation to install different types of lactone substrate, and a sequence of a

FURANONE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

The invention features compounds of the general Formula (I): (formula should be inserted here) Compounds of Formula (I) possess unexpectedly high affinity for Alk5 and/or Alk4, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including fibrotic disorders.

COMPOUND CONTAINING BASIC GROUP AND USE THEREOF

The present invention relates to a compound represented by formula (I): wherein all symbols are as defined here, a salt thereof, a solvate thereof, or a prodrug thereof. The compound of the present invention has an antagonistic activity against CXCR4 and is therefore useful as a preventive and/or therapeutic agent for CXCR4-mediated diseases, for example, inflammatory and immune diseases (for example, rheumatoid arthritis, arthritis, retinopathy, pulmonary fibrosis, rejection of transplanted organ, etc.), allergic diseases, infections (for example, human immunodeficiency virus infection, acquired immunodeficiency syndrome, etc.), psychoneurotic diseases, cerebral diseases, cardiovascular disease, metabolic diseases, and cancerous diseases (for example, cancer, cancer metastasis, etc.), or an agent for regeneration therapy.